Furthermore, we showed that tumours expressing low levels of gabarapl1 were observed to be significantly associated with high risk of metastasis in the pN+ subset (HR=14.96, P<0.001) but not in pN0 patients (Table 3). This evidence concerns the gene GABARAPL1 and neoplasm.